UNISOUND (09678) announced that the company has successfully won the bidding for the AI capability platform of Capital Medical University Beijing Friendship Hospital and multiple Agent projects. This achievement further deepens the service relationship with Beijing Friendship Hospital based on their existing cooperation and marks significant progress in the company's technology implementation and commercial applications in the smart healthcare sector.
The project leverages the company's proprietary core technologies including medical large language models, multimodal data recognition and governance, and text reasoning capabilities to construct an intelligent service platform that hospitals can operate independently. By integrating hospital knowledge bases to form medical-vertical large language models, the project breaks through traditional medical informatization construction models.
Based on this platform, the company has achieved unified management of multiple models and intelligent integration with business systems, significantly enhancing hospitals' data value mining and diagnostic efficiency in scenarios such as wound image recognition, infection risk assessment, intelligent medical record generation, and follow-up management.
For example, in the implementation at Beijing Friendship Hospital, the outpatient medical record generation system improved medical record input efficiency by 80%, saved consultation time by 15%, and substantially increased patient satisfaction.
This project represents a key initiative by the company to align with national artificial intelligence-empowered healthcare policy directions, promoting the upgrade of smart healthcare from single-scenario intelligence to comprehensive digitalization solutions covering the entire diagnostic and treatment process.
Leveraging the leading medical professional capabilities of its Shanhai large language model in authoritative evaluations such as MedBench, along with solution experience covering over 30% of the nation's top-tier Grade A tertiary hospitals, the company has further consolidated its leading position in medical intelligence competition.